Misonix to Report Fiscal 2021 Second Quarter Financial Results and Host Conference Call and Webcast on February 4
21 Enero 2021 - 9:30AM
Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive
therapeutic ultrasonic medical devices and regenerative products
that enhance clinical outcomes, announced today that it will report
its fiscal 2021 second quarter financial results after the market
closes on Thursday, February 4, 2021. The Company will host a
conference call and webcast at 4:30 p.m. ET that day to review the
results. Both the call and webcast are open to the general public.
To access the conference call, interested parties
may dial 866-248-8441 (domestic) or 323-289-6576 (international)
conference ID 2793331. Participants may also listen to a live
webcast of the call through the “Events and Presentations” section
under “Investor Relations” on Misonix’s website at www.misonix.com.
A webcast replay will be available for 30 days following the live
event at www.misonix.com.
Please call five minutes in advance to ensure that
you are connected. Questions and answers will be taken only from
participants on the conference call. For the webcast, please allow
15 minutes to register, download and install any necessary
software.
About Misonix, Inc. Misonix,
Inc. (Nasdaq: MSON) is a provider of minimally invasive
therapeutic ultrasonic medical devices and regenerative tissue
products. Its surgical team markets and sells BoneScalpel and
SonaStar, which facilitate precise bone sculpting and removal of
soft and hard tumors and tissue, primarily in the areas of
neurosurgery, orthopedic, plastic and maxillo-facial surgery. The
Company's wound team markets and sells TheraSkin, Therion,
TheraGenesis and SonicOne to debride, treat and heal chronic and
traumatic wounds in inpatient, outpatient and physician office
sites of service. At Misonix, Better Matters! That is why
throughout the Company’s history, Misonix has maintained
its commitment to medical technology innovation and the development
of products that radically improve outcomes for patients.
Additional information is available on the Company's web site at
www.misonix.com.
Contact: |
|
Joe Dwyer Chief Financial Officer Misonix, Inc.
631-927-9113 |
Norberto Aja, Jennifer Neuman
JCIR 212-835-8500 or mson@jcir.com |
Misonix (NASDAQ:MSON)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Misonix (NASDAQ:MSON)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Misonix Inc (NASDAQ): 0 recent articles
Más de Artículos de Noticias